Prescribing, deprescribing and potential adverse effects of proton pump inhibitors in older patients with multimorbidity: an observational study-Reference-Cited by-同舟云学术

Prescribing, deprescribing and potential adverse effects of proton pump inhibitors in older patients with multimorbidity: an observational study

Published:2023-01 Issue:1 Volume:11 Page:E170-E178
ISSN:2291-0026
Container-title:CMAJ Open
language:en
Short-container-title:cmajo

Author:

Aubert Carole E.,Blum Manuel R.,Gastens Viktoria,Dalleur Olivia,Vaillant Fanny,Jennings Emma,Aujesky Drahomir,Thompson Wade,Kool Tijn,Kramers Cornelius,Knol Wilma,O’Mahony Denis,Rodondi Nicolas

Publisher

CMA Impact Inc.

Subject

General Medicine

Reference23 articles.

1. A benefit-risk assessment of the use of proton pump inhibitors in the elderly;Masclee;Drugs Aging,2014

2. Proton Pump Inhibitors: Review of Emerging Concerns

3. Use of proton pump inhibitors and risk of hip fracture in relation to dietary and lifestyle factors: a prospective cohort study

4. Acid Suppressive Therapy Use on an Inpatient Internal Medicine Service

5. Longitudinal analysis of the costs associated with inpatient initiation and subsequent outpatient continuation of proton pump inhibitor therapy for stress ulcer prophylaxis in a large managed care organization;Thomas;J Manag Care Pharm,2010

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deprescribing Proton Pump Inhibitors: Updated Clinical Guidelines;The Journal for Nurse Practitioners;2024-10

2. Determinants of and interventions for Proton Pump Inhibitor prescription behavior: A systematic scoping review;BMC Primary Care;2024-06-11

3. Nuevas herramientas para la revisión de la medicación: PRM en pacientes en tratamiento con inhibidores de la bomba de protones;Atención Primaria;2024-05

4. Association between proton pump inhibitors and risk of hepatic encephalopathy in patients undergoing transjugular intrahepatic portosystemic shunt: a protocol for a systematic review and meta-analysis;BMJ Open;2024-04

5. Proton Pump Inhibitors in Germany: Status Quo of a Growing Market;Health Services Research and Managerial Epidemiology;2024-01